DNMT1 and prostate carcinoma: Notably, miR-152-3p has been reported to be frequently downregulated in prostate cancer tissues, often via promoter hypermethylation, and to function as a tumor suppressor by restraining oncogenic signaling (e.g., the DNMT1-driven epigenetic circuit) [51,52].